Abstract
Methods: The susceptibility of 417 CF patient isolates of P aeruginosa from 17 hospitals to six commonly prescribed antibiotics were examined. Isolates were tested by an agar break point dilution method and E-tests according to British Society of Antimicrobial Chemotherapy guidelines. Genotyping of isolates was performed by XbaI DNA macrorestriction and pulsed field gel electrophoresis.
Results: 38% of isolates were susceptible to all of the agents tested; almost half were resistant to gentamicin compared with ceftazidime (39%), piperacillin (32%), ciprofloxacin (30%), tobramycin (10%), and colistin (3%). Approximately 40% were resistant to two or more compounds with ceftazidime in combination with gentamicin, piperacillin or ciprofloxacin being the most common cross resistances. Resistance rates were generally similar to those reported recently from the USA and Germany. A selection of resistant isolates proved to be predominantly genotypically distinct by XbaI DNA macrorestriction but six pairs from three centres had similar genotypes.
Conclusions: The level of resistance to front line antipseudomonal agents, with the exception of colistin, is disturbingly high. The prudent use of antimicrobial drugs and closer monitoring of accumulation of resistant strain populations should be actively considered.
Full Text
The Full Text of this article is available as a PDF (126.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chen H. Y., Yuan M., Ibrahim-Elmagboul I. B., Livermore D. M. National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa. J Antimicrob Chemother. 1995 Apr;35(4):521–534. doi: 10.1093/jac/35.4.521. [DOI] [PubMed] [Google Scholar]
- Ciofu O., Giwercman B., Pedersen S. S., Høiby N. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center. APMIS. 1994 Sep;102(9):674–680. [PubMed] [Google Scholar]
- Döring G., Conway S. P., Heijerman H. G., Hodson M. E., Høiby N., Smyth A., Touw D. J. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J. 2000 Oct;16(4):749–767. doi: 10.1034/j.1399-3003.2000.16d30.x. [DOI] [PubMed] [Google Scholar]
- Govan J. R., Doherty C., Glass S. Rational parameters for antibiotic therapy in patients with cystic fibrosis. Infection. 1987 Jul-Aug;15(4):300–307. doi: 10.1007/BF01644142. [DOI] [PubMed] [Google Scholar]
- Gunn J. S., Lim K. B., Krueger J., Kim K., Guo L., Hackett M., Miller S. I. PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol. 1998 Mar;27(6):1171–1182. doi: 10.1046/j.1365-2958.1998.00757.x. [DOI] [PubMed] [Google Scholar]
- Henwood C. J., Livermore D. M., James D., Warner M., Pseudomonas Study Group Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test. J Antimicrob Chemother. 2001 Jun;47(6):789–799. doi: 10.1093/jac/47.6.789. [DOI] [PubMed] [Google Scholar]
- Jones A. M., Govan J. R., Doherty C. J., Dodd M. E., Isalska B. J., Stanbridge T. N., Webb A. K. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet. 2001 Aug 18;358(9281):557–558. doi: 10.1016/s0140-6736(01)05714-2. [DOI] [PubMed] [Google Scholar]
- KING E. O., WARD M. K., RANEY D. E. Two simple media for the demonstration of pyocyanin and fluorescin. J Lab Clin Med. 1954 Aug;44(2):301–307. [PubMed] [Google Scholar]
- Livermore David M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis. 2002 Jan 25;34(5):634–640. doi: 10.1086/338782. [DOI] [PubMed] [Google Scholar]
- MacGowan A. P., Wise R. Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. J Antimicrob Chemother. 2001 Jul;48 (Suppl 1):17–28. doi: 10.1093/jac/48.suppl_1.17. [DOI] [PubMed] [Google Scholar]
- Marley E. F., Mohla C., Campos J. M. Evaluation of E-Test for determination of antimicrobial MICs for Pseudomonas aeruginosa isolates from cystic fibrosis patients. J Clin Microbiol. 1995 Dec;33(12):3191–3193. doi: 10.1128/jcm.33.12.3191-3193.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McCallum S. J., Corkill J., Gallagher M., Ledson M. J., Hart C. A., Walshaw M. J. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa. Lancet. 2001 Aug 18;358(9281):558–560. doi: 10.1016/s0140-6736(01)05715-4. [DOI] [PubMed] [Google Scholar]
- Morlin G. L., Hedges D. L., Smith A. L., Burns J. L. Accuracy and cost of antibiotic susceptibility testing of mixed morphotypes of Pseudomonas aeruginosa. J Clin Microbiol. 1994 Apr;32(4):1027–1030. doi: 10.1128/jcm.32.4.1027-1030.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schülin Tanja. In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany. J Antimicrob Chemother. 2002 Feb;49(2):403–406. doi: 10.1093/jac/49.2.403. [DOI] [PubMed] [Google Scholar]
- Taccetti G., Campana S., Marianelli L. Multiresistant non-fermentative gram-negative bacteria in cystic fibrosis patients: the results of an Italian multicenter study. Italian Group for Cystic Fibrosis microbiology. Eur J Epidemiol. 1999 Jan;15(1):85–88. doi: 10.1023/a:1007504524034. [DOI] [PubMed] [Google Scholar]
- Williams R. J., Lindridge M. A., Said A. A., Livermore D. M., Williams J. D. National survey of antibiotic resistance in Pseudomonas aeruginosa. J Antimicrob Chemother. 1984 Jul;14(1):9–16. doi: 10.1093/jac/14.1.9. [DOI] [PubMed] [Google Scholar]
- Wolter J. M., Bowler S. D., McCormack J. G. Are antipseudomonal antibiotics really beneficial in acute respiratory exacerbations of cystic fibrosis? Aust N Z J Med. 1999 Feb;29(1):15–21. doi: 10.1111/j.1445-5994.1999.tb01583.x. [DOI] [PubMed] [Google Scholar]
- Wolter J. M., Kotsiou G., McCormack J. G. Mixed morphotype testing of Pseudomonas aeruginosa cultures from cystic fibrosis patients. J Med Microbiol. 1995 Mar;42(3):220–224. doi: 10.1099/00222615-42-3-220. [DOI] [PubMed] [Google Scholar]